Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
1P-ETH-LAD
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
5-Hydroxytryptophan
2C-D
LSM-775
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Psilocin
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Bromo-DragonFLY
2C-I
ALD-52
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:40mg - Brothermind and the Forest's Hand
2C-T-2
25I-NBOMe
5-MeO-DiPT
Coluracetam
2C-C
DOI
25C-NBOH
3-MMC
MDAI
Experience:250mg DXM - DXM Itch and Trip Report
Experience:1mg 25c-NBOMe - Experiment in my room
MDEA
Escaline
TMA-2
LSZ
Efavirenz
25I-NBOH
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Allylescaline
3-MeO-PCE
DOC
Pregabalin
Ayahuasca
Tree.jpgJapanese Garden by Anonymous
Phenylpiracetam
JWH-018
4-HO-DiPT
1B-LSD
ΑMT
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
MiPLA
5-MeO-MiPT
MDMA
GABAergic hallucinogens
4-AcO-DMT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
3C-E
4-HO-MiPT
4-FA
25D-NBOMe
MDA
Experience:120mg - Garden of The Gods
4-HO-MPT
EPT
Mescaline
2C-B
Experience:~150mg MDA(oral) - a case of mistaken identity
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Memantine
Experience:3-MeO-PCP - Extreme psychosis
Experience:BK-2C-B - Various experiences
4-AcO-DET
Paradise island by Xanny.jpgParadise island by Subsentience
Aniracetam
TMA-6
Experience:25mg Deschloroketamine - My first time orally dosing DCK
MiPT
Psilocybin mushrooms
Experience:1000 Morning Glory seeds - Rediscovering the Self
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
LSD
Amanita muscaria
THJ-2201
Piracetam
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Phenethylamine (compound)
Experience:4x 200ug tabs - You do not need to understand
5F-PB-22
Cannabis
Omberacetam
5-MeO-DALT
2C-B-FLY
ETH-LAD
DOM
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
JWH-073
Chameleon.jpgChameleon by Anonymous.
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Selective serotonin reuptake inhibitor
1P-LSD
DET
THJ-018
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
PRO-LAD
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
MPT
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Bufotenin
Experience:800 seeds LSA - My First Trip Ever
25B-NBOH
DOB
Experience:4-HO-MiPT / A care free psychedelic getaway
Pramiracetam
Experience:4.5g - The Grand Introduction to Beauty and Fear
5-MeO-DiBF
DMT
6-APDB
2C-H
DiPT
Ibogaine
25N-NBOMe
25B-NBOMe
4-HO-EPT
6-APB
4-AcO-DiPT
Experience:300µg LSD - Togetherness and the Silent Dusk
Proscaline
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
MET
Methallylescaline
Experience:4-AcO-DMT + 200mg Pill
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-AcO-MiPT
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
25C-NBOMe
DPT
4-HO-DET
PARGY-LAD
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
AL-LAD
2C-P
Enhancement of colour rose.jpgRose by Chelsea Morgan
Oxiracetam
Experience:337mg DMT fumarate - A Day With DMT
Experience:2 tabs DOB - My DOB Nightmare
2C-T-21
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
4-HO-DPT
4-AcO-MET
Βk-2C-B
4-HO-MET
2C-T-7
LSA
Experience:1050 µg 1cP-LSD - The matrix
2C-E

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.